ERBB2 and breast cancer: While FVBN202 transgenic mice tolerate neu-overexpressing mammary tumor similar to human counterpart, FVB mice mount alloreactive anti-neu immune responses and serve as negative control for studying distant tumor dormancy in FVBN202 transgenic mice.